Bluejay Diagnostics, Inc. (BJDX)
NASDAQ: BJDX · Real-Time Price · USD
3.450
-0.080 (-2.27%)
At close: Feb 21, 2025, 4:00 PM
3.770
+0.320 (9.28%)
After-hours: Feb 21, 2025, 6:03 PM EST
Bluejay Diagnostics Market Cap
Bluejay Diagnostics has a market cap or net worth of $1.85 million as of February 21, 2025. Its market cap has increased by 20.21% in one year.
Market Cap
1.85M
Enterprise Value
-3.64M
1-Year Change
20.21%
Ranking
Category
Stock Price
$3.45
Market Cap Chart
Since the IPO on November 10, 2021, Bluejay Diagnostics's market cap has decreased from $67.50M to $1.85M, a decrease of -97.25%. That is a compound annual growth rate of -66.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 21, 2025 | 1.85M | -29.16% |
| Dec 31, 2024 | 2.62M | 73.26% |
| Dec 29, 2023 | 1.51M | -80.26% |
| Dec 30, 2022 | 7.66M | -84.66% |
| Dec 31, 2021 | 49.91M | -26.06% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 785.48B |
| UnitedHealth Group | 464.00B |
| Johnson & Johnson | 378.55B |
| Novo Nordisk | 365.53B |
| AbbVie | 348.30B |
| AstraZeneca | 230.61B |
| Abbott Laboratories | 227.66B |
| Intuitive Surgical | 215.60B |